Literature DB >> 16877531

The inflammatory reflex and risk for rheumatoid arthritis: a case-control study of human vagotomy.

Cecilia Carlens1, Lena Brandt, Lars Klareskog, Jon Lampa, Johan Askling.   

Abstract

Recent data suggest remarkable effects of vagus stimulation (reduction) and vagotomy (exacerbation) on acute inflammation in rats, the so-called "inflammatory reflex". Its role in humans remains unknown. Therefore, the aim was to explore whether surgical vagotomy in humans would affect the risk of a prototype inflammatory disease, rheumatoid arthritis. This was a case-control study. Assessment of the relative risk (RR) of developing rheumatoid arthritis after surgical vagotomy during 1964-2001 in 63,092 prevalent rheumatoid arthritis cases versus 125,404 matched controls from the general population and in 2548 incident rheumatoid arthritis cases versus 24,357 matched controls from the general population, respectively, was done. For comparison, we assessed RRs for hospitalisation for gastric disorders not including vagotomy. Data on exposures and rheumatoid arthritis were retrieved from population-based and prospectively recorded Swedish registers. A pre-rheumatoid arthritis vagotomy was not significantly associated with an increased risk for rheumatoid arthritis (RR = 1.17, 95% CI 0.97 to 1.40). RRs in the same range were observed for several other pre-rheumatoid arthritis gastric conditions that do not include vagotomy (eg, gastric ulcer RR = 1.21, 95% 1.11 to 1.33). Vagotomy has no specific effect on the risk of developing rheumatoid arthritis in humans. Gastroduodenal ulcers occur more often than expected even before the occurrence of rheumatoid arthritis.

Entities:  

Mesh:

Year:  2006        PMID: 16877531      PMCID: PMC1855998          DOI: 10.1136/ard.2006.055285

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  9 in total

Review 1.  On the organization of an early arthritis clinic.

Authors:  L Klareskog; B Nordmark; S Lindblad
Journal:  Best Pract Res Clin Rheumatol       Date:  2001-03       Impact factor: 4.098

2.  Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin.

Authors:  L V Borovikova; S Ivanova; M Zhang; H Yang; G I Botchkina; L R Watkins; H Wang; N Abumrad; J W Eaton; K J Tracey
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

3.  Nonsteroidal antiinflammatory drug use and gallstone disease prevalence: a case-control study.

Authors:  P Pazzi; R Scagliarini; D Sighinolfi; M Govoni; R La Corte; S Gullini
Journal:  Am J Gastroenterol       Date:  1998-09       Impact factor: 10.864

Review 4.  Is smoking still important in the pathogenesis of peptic ulcer disease?

Authors:  G L Eastwood
Journal:  J Clin Gastroenterol       Date:  1997       Impact factor: 3.062

5.  Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation.

Authors:  L V Borovikova; S Ivanova; D Nardi; M Zhang; H Yang; M Ombrellino; K J Tracey
Journal:  Auton Neurosci       Date:  2000-12-20       Impact factor: 3.145

Review 6.  Mechanisms of disease: nicotine--a review of its actions in the context of gastrointestinal disease.

Authors:  Gareth A O Thomas; John Rhodes; John R Ingram
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2005-11

Review 7.  Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases.

Authors:  P Stolt; C Bengtsson; B Nordmark; S Lindblad; I Lundberg; L Klareskog; L Alfredsson
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

8.  Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.

Authors:  Hong Wang; Man Yu; Mahendar Ochani; Carol Ann Amella; Mahira Tanovic; Seenu Susarla; Jian Hua Li; Haichao Wang; Huan Yang; Luis Ulloa; Yousef Al-Abed; Christopher J Czura; Kevin J Tracey
Journal:  Nature       Date:  2002-12-22       Impact factor: 49.962

9.  Pharmacological stimulation of the cholinergic antiinflammatory pathway.

Authors:  Thomas R Bernik; Steven G Friedman; Mahendar Ochani; Robert DiRaimo; Luis Ulloa; Huan Yang; Samridhi Sudan; Christopher J Czura; Svetlana M Ivanova; Kevin J Tracey
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

  9 in total
  6 in total

Review 1.  Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis.

Authors:  Frieda A Koopman; Susanne P Stoof; Rainer H Straub; Marjolein A Van Maanen; Margriet J Vervoordeldonk; Paul P Tak
Journal:  Mol Med       Date:  2011-05-20       Impact factor: 6.354

2.  Lack of acetylcholine nicotine alpha 7 receptor suppresses development of collagen-induced arthritis and adaptive immunity.

Authors:  M Westman; S Saha; M Morshed; J Lampa
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

Review 3.  The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis.

Authors:  Marjolein A van Maanen; Margriet J Vervoordeldonk; Paul P Tak
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

Review 4.  The interface between cholinergic pathways and the immune system and its relevance to arthritis.

Authors:  Robin M McAllen; Andrew D Cook; Hsu Wei Khiew; Davide Martelli; John A Hamilton
Journal:  Arthritis Res Ther       Date:  2015-03-31       Impact factor: 5.156

5.  Acid-reducing vagotomy is associated with reduced risk of subsequent ischemic heart disease in complicated peptic ulcer: An Asian population study.

Authors:  Shih-Chi Wu; Chu-Wen Fang; William Tzu-Liang Chen; Chih-Hsin Muo
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

6.  Gut-Sourced Vasoactive Intestinal Polypeptide Induced by the Activation of α7 Nicotinic Acetylcholine Receptor Substantially Contributes to the Anti-inflammatory Effect of Sinomenine in Collagen-Induced Arthritis.

Authors:  MengFan Yue; XinYu Zhang; YanNong Dou; ZhiFeng Wei; Yu Tao; YuFeng Xia; Yue Dai
Journal:  Front Pharmacol       Date:  2018-06-26       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.